ACTINIUM PHARMACEUTICALS, INC. Earnings Per Share (Basic)
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Earnings Per Share (Basic) of $0.89 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-07
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.89.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.18.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.16.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for the quarter ending 2025-06-30 was -$0.22.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2025 was -$1.09.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2024 was -$1.27.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2023 was -$1.83.
- ACTINIUM PHARMACEUTICALS, INC. earnings per share, basic for fiscal 2022 was -$1.37.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.89 10-Q · filed 2026-08-07 | $0.71 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | -$0.18 10-Q · filed 2026-05-08 | |||
| 2025-12-31 | -$1.09 10-K · filed 2026-03-30 | |||
| 2025-09-30 | -$0.16 10-Q · filed 2025-11-14 | -$0.90 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | -$0.22 10-Q · filed 2026-08-07 | -$0.73 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | -$0.51 10-Q · filed 2026-05-08 | |||
| 2024-12-31 | -$1.27 10-K · filed 2026-03-30 | |||
| 2024-09-30 | -$0.37 10-Q · filed 2025-11-14 | -$1.06 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | -$0.38 10-Q · filed 2025-08-08 | -$0.69 10-Q · filed 2025-08-08 | ||
| 2024-03-31 | -$0.31 10-Q · filed 2025-05-09 | |||
| 2023-12-31 | -$1.83 10-K · filed 2025-03-31 | |||
| 2023-09-30 | -$0.49 10-Q · filed 2024-11-14 | -$1.50 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$0.58 10-Q · filed 2024-08-05 | -$1.01 10-Q · filed 2024-08-05 | ||
| 2023-03-31 | -$0.43 10-Q · filed 2024-04-26 | |||
| 2022-12-31 | -$1.37 10-K · filed 2024-03-29 | |||
| 2022-09-30 | -$0.38 10-Q · filed 2023-11-02 | -$0.94 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$0.33 10-Q · filed 2023-08-14 | -$0.56 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | -$0.23 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.91 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$1.20 10-K · filed 2023-03-31 |
| 2021-09-30 | -$0.30 10-Q · filed 2022-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.84 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$0.25 10-Q · filed 2022-08-12 | -$0.54 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$0.29 10-Q · filed 2022-05-13 | |||
| 2016-09-30 | -$0.14 10-Q · filed 2016-10-28 | -$0.38 10-Q · filed 2016-10-28 | ||
| 2016-06-30 | -$0.15 10-Q · filed 2016-07-29 | -$0.25 10-Q · filed 2016-07-29 | ||
| 2015-09-30 | -$0.10 10-Q · filed 2016-10-28 | -$0.39 10-Q · filed 2016-10-28 | ||
| 2015-06-30 | -$0.20 10-Q · filed 2016-07-29 | -$0.30 10-Q · filed 2016-07-29 | ||
| 2014-06-30 | $0.14 10-Q · filed 2015-08-07 | -$0.52 10-Q · filed 2015-08-07 | ||
| 2013-06-30 | -$0.13 10-Q · filed 2014-08-12 | -$0.16 10-Q · filed 2014-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |